Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2003
08/28/2003US20030161820 Prevent infections; antiulcer agents
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030159914 Plant extracts from fruit pits; presoaking in water, distillation; separation by specific gravity; bactericides, antiseptics; sterilization
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2473078A1 Method for producing interferon
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2380471A1 Oral dna vaccine composition for hepatitis b virus chronic infection
08/27/2003EP1338597A1 1,4,5,6-tetrahydroimidazo 4,5-d]diazepine derivatives or salts thereof
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337550A2 Hepatitis c tripeptide inhibitors
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337540A2 Motilide compounds
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337252A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
08/27/2003EP1337236A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1014952B1 Multiple unit effervescent dosage form
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0936905B1 Immediate wettability water soluble film or water soluble layer for oral application
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0891363B1 Heterocyclic compounds and their preparation and use
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0832186B1 Replacement therapy for dental caries
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439049A Hepatocyte lineage cells derived from pluripotent stem cells
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438895A Peptide composition
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
08/27/2003CN1438225A Ginger-yellow pigment metal-ion complex, its preparation method and use
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1438015A Medicine for treating colontis and preparation method thereof
08/27/2003CN1438013A Use of Herba salviae plebeiae in preparing medicine for treating gestric ulcer
08/27/2003CN1438010A Children's health-care tonic eiquor for promoting function of digestion and assimilation
08/27/2003CN1438003A Gel pill containg pine-nut oil and Radix oenotherae Erythrosepalae oil
08/27/2003CN1438002A Capsule for treating stomach and duodenal ulcer and preparation method
08/27/2003CN1437994A Ascites pill and its preparation method
08/27/2003CN1437988A Liver-protecting and sobering capsule and its production method
08/27/2003CN1437987A Weibingkang for treating stomach disease and preparation method
08/27/2003CN1437986A Liver-relieving kidney-nourishing liquid
08/27/2003CN1437979A Oral medicine for treating disease of digestive system such as gastric ulcer
08/27/2003CN1437971A Toxicant-elimination medicine
08/27/2003CN1437969A Chinese medicine preparation for treating hepatitis B and preparation method
08/27/2003CN1437967A Medicine for treating appendicitis
08/27/2003CN1437954A Nutrient tablet for sobering and protecting liver
08/27/2003CN1437953A Gentiamarin powder infection for muscle injection and intravenous injection
08/27/2003CN1437944A Technology for producing Dekuiluan lozenge
08/27/2003CN1437941A Preparation method for soft capsule of matrine for treating arythmia and acute enteritis
08/27/2003CN1437939A Method for induding andrographolide by cyclodextrin and medicinal preparation
08/27/2003CN1437937A Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119167C Health beverage capable of invigorating spleen and stomach
08/27/2003CN1119159C Medicine for curing stomatocase
08/27/2003CN1119158C Youth and longevity pellet and its preparation
08/27/2003CN1119147C Kappa-opiate agonists for inflammatory bowel disorders
08/27/2003CN1119145C Liposomal compositions and method of using them
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610732 For relieving or preventing constipation in a human constipated patient or preparing a bowel prior to preventative, diagnostic or surgical procedures
08/26/2003US6610717 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
1 ... 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 ... 1258